Up date nutritional support for patients with COPD

Respiratory Medicine: COPD Update

Volumn 4, Issue 4, 2008, Pages 127-131

  Ferreira, Ivone Martins ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anabolic steroids; Anabolic substances; COPD; Nutritional support

Indexed keywords

ANABOLIC AGENT; APPETITE STIMULANT; GHRELIN; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; MEGESTROL ACETATE; SOMATOMEDIN; STANOZOLOL; TESTOSTERONE;

ANDROGEN THERAPY; ANTHROPOMETRY; ARTICLE; CACHEXIA; CALORIC INTAKE; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; GENETIC POLYMORPHISM; HORMONE ACTION; HUMAN; INFLAMMATION; KINESIOTHERAPY; LEAN BODY WEIGHT; MALNUTRITION; MUSCLE ATROPHY; MUSCLE MASS; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN INTAKE; PROTEIN METABOLISM; QUALITY OF LIFE; RESPIRATORY FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; UNDERWEIGHT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 55649099422     PISSN: 17450454     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmedu.2008.08.004     Document Type: Article

References (37)

1. O'Donnell DE, Hernandez P, Kaplan A, Aaron S, Bourbeau J, Marciniuk D, et al. Canadian thoracic society recommendations for management of chronic obstructive pulmonary disease-2008 update-highlights for primary care. Can Respir J 2008;15(Suppl. A):1A-8A. Proc Am Thorac Soc. 2008;5(4):519-23.
2. Wouters E.F., Creutzberg E.C., and Schols A.M. Systemic effects in COPD. Chest 121 5 Suppl. (2002) 127S-130S
3. Donahoe M. Nutritional support in advanced lung disease; the pulmonary cachexia syndrome. Clin Chest Med 18 3 (1997) 547-561
4. Sahebjami H., Doers J.T., Render M.L., and Bond T.L. Anthropometric and pulmonary function test profiles of outpatients with stable chronic obstructive pulmonary disease. Am J Med 94 5 (1993) 469-474
5. Sahebjami H., and Sathianpitayakul E. Influence of body weight on the severity of dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 3 Pt 1 (2000) 886-890
6. Engelen MP, Schols AM, Lamers RJ, Wouters EF. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 1999;18(5):275-280. Eur Respir J. 2008;31(3):492-501.
7. Biskobing D.M. COPD and osteoporosis. Chest 121 2 (2002) 609-620
8. Katsura H., and Kida K. Comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest 117 5 Suppl. 1 (2000) 280S
9. Incalzi R.A., Caradonna P., Ranieri P., et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 94 (2000) 1079-1084
10. Jardim J.R.B., Ferreira I.M., and Sacks A. Nutrition, anabolic steroids and growth hormone. Phys Med Rehabil Clin North Am 7 (1996) 253-275
11. Lewis M.I. Nutrition in chronic obstructive pulmonary disease. A clinical overview. In: Bach J.R. (Ed). Pulmonary rehabilitation: the obstructive and paralytic conditions (1996), Hanley & Belfus, Philadelphia 157-171
12. Vitacca M., Clini E., Porta R., Foglio K., and Ambrosino N. Acute exacerbations in patients with COPD: predictors of need for mechanical ventilation. Eur Respir J 9 7 (1996) 1487-1493
13. Wagner P.D. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31 3 (2008) 492-501
14. Itoh T., Nagaya N., Yoshikawa M., Fukuoka A., Takenaka H., Shimizu Y., et al. Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 8 (2004) 879-882
15. King D.A., Cordova F., and Scharf S.M. Nutritional aspects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 5 4 (2008) 519-523
16. Agustí A.G., Sauleda J., Miralles C., Gomez C., Togores B., Sala E., et al. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 4 (2002) 485-489
17. Lewis M.I. Apoptosis as a potential mechanism of muscle cachexia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 4 (2002) 434-436
18. Schols A.M., and Wouters E.F. Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease. Clin Chest Med 21 4 (2000) 753-762
19. Ferreira I.M., Brooks D., Lacasse Y., Goldstein R.S., and White J. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2 (2005) CD000998
20. Ferreira I.M., Brooks D., Lacasse Y., and Goldstein R.S. Nutritional support for individuals with COPD: a meta-analysis. Chest 117 3 (2000) 672-678
21. Ferreira I., Brooks D., Lacasse Y., and Goldstein R. Nutritional intervention in COPD: a systematic overview. Chest 119 2 (2001) 353-363
22. Rogers R.M., Donahoe M., and Costantino J. Physiologic effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study. Am Rev Respir Dis 146 6 (1992) 1511-1517
23. Steiner M.C., Barton R.L., Singh S.J., and Morgan M.D. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 58 9 (2003) 745-751
24. Weekes C.E., Elia M., and Emery P.W. Tailored dietary advice and food fortification in patients with chronic obstructive pulmonary disease (COPD). Clin Nutr 23 (2004) 1493
25. Schols A.M.W.J. Nutrition and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J 22 Suppl. 46 (2003) 81s-86s
26. Baldwin C., Parsons T., and Logan S. Dietary advice for illness-related malnutrition in adults. Cochrane Database Syst Rev 1 (2001) CD002008
27. Baldwin C., and Weekes C.E. Dietary advice for illness-related malnutrition in adults. Cochrane Database Syst Rev 2 (2008) CD002008
28. Bhasin S., Storer T.W., Berman N., Callegari C., Clevenger B., Phillips J., et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335 1 (1996) 1-7
29. Ferreira I.M., Verreschi I.T., Nery L.E., Goldstein R.S., Zamel N., Brooks D., et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 114 1 (1998) 19-28
30. Ferreira IM, Verreschi ITN, Cedenho A, et al. Assessment of prostate size in patients with COPD treated with anabolic steroids, submitted for publication.
31. Schols A.M., Soeters P.B., Mostert R., Pluymers R.J., and Wouters E.F. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152 4 Pt 1 (1995) 1268-1274
32. Casaburi R., Bhasin S., Cosentino L., Porszasz J., Somfay A., Lewis M.I., et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 8 (2004) 870-878 [Epub 2004 Jul 21]
33. Lewis M.I., Fournier M., Storer T.W., Bhasin S., Porszasz J., Ren S.G., et al. Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol 103 4 (2007) 1299-1310
34. Burdet L., de Muralt B., Schutz Y., Pichard C., and Fitting J.W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med 156 6 (1997) 1800-1806
35. Casaburi R., Carithers E., Tosoline J., et al. Randomized controlled trial of growth hormone in severe COPD patients undergoing endurance exercise training. Am J Respir Crit Care Med 155 (1997) A498
36. Weisberg J., Wanger J., Olson J., Streit B., Fogarty C., Martin T., et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest 121 4 (2002) 1070-1078
37. Schols A.M., Slangen J., Volovics L., and Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 6 Pt 1 (1998) 1791-1797